Showing results (251-260 of 265) with videos related to
Sort By:
Pageof 27
Journal of the Society for Cardiovascular Angiography & Interventions|August 12, 2024
Management of Patients With Kidney Disease in Need of Cardiovascular Catheterization: A Scientific Workshop Cosponsored by the National Kidney Foundation and the Society for Cardiovascular Angiography and InterventionsAnand Prasad, Paul M Palevsky, Shweta Bansal, et al.JACC. Cardiovascular Interventions|October 20, 2022
Position Statement on Vascular Access Safety for Percutaneous Devices in AMI Complicated by Cardiogenic ShockAbdulla A Damluji, Behnam Tehrani, Shashank S Sinha, et al.Toxicological Sciences : an Official Journal of the Society of Toxicology|December 13, 2021
Guiding Chemically Synthesized Peptide Drug Lead Optimization by Derisking Mast Cell Degranulation-Related Toxicities of a NaV1.7 Peptide InhibitorPierre Morissette, Nianyu Li, Jeanine E Ballard, et al.Environmental Health Perspectives|March 23, 2004
Identification of putative gene based markers of renal toxicityRupesh P Amin, Alison E Vickers, Frank Sistare, et al.International Journal of Radiation Oncology, Biology, Physics|September 4, 2021
Adding Short-Term Androgen Deprivation Therapy to Radiation Therapy in Men With Localized Prostate Cancer: Long-Term Update of the NRG/RTOG 9408 Randomized Clinical TrialChristopher U Jones, Stephanie L Pugh, Howard M Sandler, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 2, 2023
CNS Efficacy of Osimertinib With or Without Chemotherapy in Epidermal Growth Factor Receptor-Mutated Advanced Non-Small-Cell Lung CancerPasi A Jänne, David Planchard, Kunihiko Kobayashi, et al.Journal of Medicinal Chemistry|March 29, 2022
Lead Optimization to Advance Protease-Activated Receptor-1 Antagonists in Early DiscoveryMihirbaran Mandal, Maria Madeira, Rupesh P Amin, et al.Nature Communications|May 7, 2026
Nivolumab plus ipilimumab for chemotherapy-refractory metastatic castration-resistant prostate cancer: results from the randomized portion of the phase 2 CheckMate 650 trialPadmanee Sharma, Michael Krainer, Fred Saad, et al.Journal of Medicinal Chemistry|November 10, 2020
Series of Novel and Highly Potent Cyclic Peptide PCSK9 Inhibitors Derived from an mRNA Display Screen and Optimized via Structure-Based DesignCandice Alleyne, Rupesh P Amin, Bhavana Bhatt, et al.Bioorganic & Medicinal Chemistry Letters|October 13, 2024
Discovery of sulfone containing metallo-β-lactamase inhibitors with reduced bacterial cell efflux and histamine release issuesFrank Bennett, Yuhua Huang, Shuzhi Dong, et al.Pageof 27